propranolol has been researched along with lysophosphatidylcholines in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 10 (66.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, YS; Hii, CS; Murray, AW | 1 |
| Rogausch, H | 1 |
| Gauffin, ML; Saris, NE; Seppälä, AJ | 1 |
| Barton, M; Lefort, J; Prancan, A; Vargaftig, BB | 1 |
| Abiko, Y; Hashizume, H; Hoque, AN; Hoque, N | 1 |
| Ikeda, U; Shigenobu, K; Tanaka, H | 1 |
| Anderson, R; Ramafi, G; Theron, AJ | 1 |
| Akiba, S; Ishimoto, T; Sato, T | 1 |
| Abiko, Y; Hara, A; Hashizume, H | 1 |
| Abiko, Y; Chen, M; Hara, A; Hashizume, H; Xiao, CY | 1 |
| Abiko, Y; Hara, A; Hashizume, H; Hoque, AN; Magishi, K | 1 |
| Abiko, Y; Hara, A; Hashizume, H; Ma, H; Yazawa, K | 1 |
| Bohrer, A; Hsu, FF; Ma, Z; Ramanadham, S; Turk, J | 1 |
| Awaya, T; Hara, A; Hayase, N; Matsubara, K; Satomi, M; Shimizu, K | 1 |
| Choi, YW; Lee, J | 1 |
1 review(s) available for propranolol and lysophosphatidylcholines
| Article | Year |
|---|---|
[A new approach to the understanding of the mechanism of ischemia/reperfusion damage in the heart and the effects of anti-ischemic drugs].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Circulation; Dilazep; Diltiazem; Energy Metabolism; Humans; Lysophosphatidylcholines; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oxygen Consumption; Palmitoylcarnitine; Propranolol; Vasodilator Agents | 1996 |
14 other study(ies) available for propranolol and lysophosphatidylcholines
| Article | Year |
|---|---|
Phorbol ester-stimulated hydrolysis of phosphatidylcholine and phosphatidylethanolamine by phospholipase D in HeLa cells. Evidence that the basal turnover of phosphoglycerides does not involve phospholipase D.
Topics: Choline; Fatty Alcohols; HeLa Cells; Humans; Hydrolysis; Lysophosphatidylcholines; Palmitic Acids; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipase D; Propranolol; Tetradecanoylphorbol Acetate | 1991 |
Influence of shape stabilizing agents on the deformability and morphology of lysolecithin-treated erythrocytes.
Topics: Blood Viscosity; Erythrocyte Deformability; Erythrocytes; Humans; Lysophosphatidylcholines; Papaverine; Parasympatholytics; Propranolol | 1988 |
Inhibition of phospholipase A-induced swelling of mitochondria by local anesthetics and related agents.
Topics: 4-Aminobenzoic Acid; Amines; Anesthetics, Local; Animals; Chlorpromazine; Dibucaine; Fatty Acids; Fatty Acids, Nonesterified; Kinetics; Lysophosphatidylcholines; Mitochondria; Mitochondrial Swelling; Phospholipases; Promethazine; Propranolol; Rats; Snakes; Spermidine; Spermine; Time Factors; Venoms | 1971 |
Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin.
Topics: Acetylcholine; Animals; Aspirin; Blood Platelets; Female; Guinea Pigs; Histamine; In Vitro Techniques; Lysophosphatidylcholines; Male; Methysergide; Muscle Relaxation; Phenoxybenzamine; Platelet Activating Factor; Propranolol; Serotonin; Trachea | 1982 |
A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart.
Topics: Animals; Blood Pressure; Dilazep; Fatty Acids, Nonesterified; Heart; Heart Rate; In Vitro Techniques; Lactates; Lactic Acid; Lidocaine; Lysophosphatidylcholines; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Phosphates; Propranolol; Rats; Rats, Sprague-Dawley | 1995 |
Positive chronotropic and inotropic responses to lysophosphatidylcholine are mediated by norepinephrine released from myocardial sympathetic nerve terminals.
Topics: Animals; Heart; Heart Rate; In Vitro Techniques; Lysophosphatidylcholines; Male; Myocardial Contraction; Myocardium; Nerve Endings; Norepinephrine; Propranolol; Rats; Rats, Wistar; Reserpine; Stimulation, Chemical; Sympathetic Nervous System | 1993 |
Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils.
Topics: Acridines; Adenosine Triphosphate; Antioxidants; Calcium; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Luminescent Measurements; Lysophosphatidylcholines; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Propranolol | 1996 |
Importance of the phospholipase D-initiated sequential pathway for arachidonic acid release and prostaglandin D2 generation by rat peritoneal mast cells.
Topics: Adenosine Diphosphate Ribose; ADP-Ribosylation Factors; Animals; Arachidonic Acid; Brain; Cattle; Choline; Cyclohexanones; Dinitrophenols; Enzyme Activation; Enzyme Inhibitors; Ethanol; GTP-Binding Proteins; Inositol; Inositol Phosphates; Ionomycin; Kinetics; Lipoprotein Lipase; Lysophosphatidylcholines; Male; Mast Cells; Melitten; Peritoneal Cavity; Phospholipase D; Propranolol; Prostaglandin D2; Rats; Rats, Wistar; Receptors, IgE; Serum Albumin, Bovine | 1996 |
Lysophosphatidylcholine induces Ca2+-independent cellular injury attenuated by d-propranolol in rat cardiomyocytes.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Cells, Cultured; Creatine Kinase; Heart; Heart Ventricles; Lysophosphatidylcholines; Male; Myocardium; Propranolol; Rats; Rats, Sprague-Dawley; Ryanodine; Sarcoplasmic Reticulum | 1997 |
A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Cats; Dilazep; Enzyme Activation; Heart; Humans; In Vitro Techniques; Lysophosphatidylcholines; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Phospholipases A; Phospholipases A2; Propranolol; Rats; Swine; Tetrodotoxin | 1997 |
Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium; Cell Size; Creatine Kinase; Enalapril; Enalaprilat; Isoquinolines; Lysophosphatidylcholines; Male; Micelles; Myocardium; Propranolol; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Vasodilator Agents | 1999 |
Studies of the role of group VI phospholipase A2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells.
Topics: Animals; Arachidonic Acid; Cricetinae; Enzyme Inhibitors; Ethylmaleimide; Fatty Acids; Group VI Phospholipases A2; Insulinoma; Interleukin-1; Islets of Langerhans; Lysophosphatidylcholines; Male; Naphthalenes; omega-N-Methylarginine; Phosphodiesterase Inhibitors; Phospholipases A; Phospholipases A2; Phospholipids; Propranolol; Pyrones; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1999 |
Protective effects of quinaprilat and trandolaprilat, active metabolites of quinapril and trandolapril, on hemolysis induced by lysophosphatidylcholine in human erythrocytes.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Hemolysis; Humans; Hypotonic Solutions; In Vitro Techniques; Indoles; Lysophosphatidylcholines; Micelles; Propranolol; Quinapril; Sodium Chloride; Tetrahydroisoquinolines | 2003 |
Enhanced ex vivo buccal transport of propranolol: evaluation of phospholipids as permeation enhancers.
Topics: Absorption; Administration, Buccal; Animals; Drug Synergism; Ethanol; Fusidic Acid; In Vitro Techniques; Lysophosphatidylcholines; Mouth Mucosa; Permeability; Phosphatidylcholines; Propranolol; Swine | 2003 |